Here’s a look back at some of the life science industry’s executive appointments, departures, and retirements from recent weeks:
—Pacific Biosciences (NASDAQ: PACB) CEO Michael Hunkapiller and Chief Financial Officer Susan Barnes are retiring.
—Sensei Biotherapeutics appointed Marie-Louise Fjällskog its chief medical officer.
—Jim Malone joined Bigfoot Biomedical as chief medical officer.
— Frank Sanders was appointed president of Zealand Pharma US.
—Abcentra appointed Kevin B. Bacon its CEO.
—Ambaw Bellete was appointed chief operating officer of FerGene.
—David Spellman is joining Akebia Therapeutics as senior vice president, chief financial officer, and treasurer.
—Neuraptive Therapeutics announced Robert (Bob) S. Radie as its new CEO.
—Storm Therapeutics appointed Josefin-Beate Holz as clinical advisor and chief medical officer.
—Mereo BioPharma Group (NASDAQ: MREO) appointed John Lewicki its chief scientific officer.
—Akcea Therapeutics (NASDAQ: AKCA) named Tracy Palmer Berns its chief compliance officer.